Open access
Heterogeneity in plasma p‐tau217 response and its association with cognitive trajectories under lecanemab treatment
Sung-Hoon Kang
Yu Jeong Park
Seung-Yun Lee
Jimin Kang
Seongin Lee
Eun Seong Lee
Hye Na Jung
I. Ryoo
Hyundoo Hwang
Kwangho Choi
Jae Seon Eo
Sang-Il Suh
Kyungmi Oh
Seong-Beom Koh
Medicine
Abstract
Plasma phosphorylated tau 217 (p‐tau217) is a promising biomarker for monitoring treatment response in Alzheimer's disease (AD), but its longitudinal dynamics and clinical relevance remain unclear.